Actively Recruiting
Study of Atmospheric Pressure Cold Plasma to Treat Moderate-to-Severe Athletes Foot A Randomized, Double-Blind, Placebo-Controlled Trial Evaluating Safety and Effectiveness
Led by Shenyang Medical College · Updated on 2026-01-02
220
Participants Needed
1
Research Sites
5 weeks
Total Duration
AI-Summary
What This Trial Is About
Tinea pedis, commonly known as athletes foot, is a contagious fungal infection affecting the feet, often causing symptoms like redness, scaling, itching, and in severe cases, blistering and skin breakdown. Moderate-to-severe cases involve extensive skin lesions, intense symptoms, frequent recurrences, and higher risks of complications such as bacterial infections. Current treatments often fail due to poor drug penetration, fungal resistance, and complex treatment procedures, impacting patients quality of life and daily functioning. This research aims to evaluate atmospheric pressure cold plasma CAP, a novel technology with antimicrobial and healing properties, as a potential treatment for moderate-to-severe tinea pedis. Participants will be randomly assigned to either the CAP treatment group or a sham placebo group. Those in the CAP group will receive 13 sessions of CAP therapy involving plasma-activated gas rich in ozone and nitric oxide applied to the affected foot area, initially daily for five days and then every other day. The sham group will undergo a similar procedure without plasma generation to maintain study blinding. Both groups will continue to receive standard care according to clinical guidelines throughout the study. During the trial, participants will attend multiple visits where researchers will measure changes in lesion size, time to lesion improvement, and quality of life using questionnaires. Safety will be monitored by tracking skin irritation and local burning sensations at each visit. The treatment effect will be assessed over a period of approximately 20 days from randomization, with follow-up visits to evaluate outcomes and ensure participant safety. The study is designed to provide data on CAPs potential to improve treatment options for those with moderate-to-severe tinea pedis.
CONDITIONS
Brief Title
Atmospheric Pressure Cold Plasma for Moderate-to-severe Tinea Pedis
Research Team
Y
Yun-En Liu, MD
L
Lin Tao, MM
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here